Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse in Adults With ADHD (Workplace Environment Study)
NCT00697515Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2008
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
A Phase 3 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Jul 2008; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00697515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697515.